Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Therapy With TCR Gene-engineered T Cells to Treat Patients With MAGE-C2-positive Melanoma and Head and Neck Cancer

NCT04729543 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04729543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Therapy With TCR Gene-engineered T Cells to Treat Patients With MAGE-C2-positive Melanoma and Head and Neck Cancer
Lead sponsor
Erasmus Medical Center
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 20, 2020
Completion date
October 20, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, melanoma, melanoma, uveal